Ads
related to: Abbvie- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Our Science
See How We Impact Lives.
More Than Developing Medicines.
- AbbVie News Center
Search results
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Motley Fool via Yahoo Finance· 8 hours agoThere are magnificent stocks to buy in other industries, such as healthcare, which may provide...
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 1 day agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately ...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 6 days agoWall Street is feeling pretty good about AbbVie's (NYSE: ABBV) performance in 2024 so far. Louise...
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 3 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
2 Billion More Reasons to Buy AbbVie Stock
Motley Fool via Yahoo Finance· 4 days agoThere are plenty of reasons to buy a leading biopharma business like AbbVie (NYSE: ABBV), and investors just got at least a few more. Thanks to a large...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 2 days agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 4 days agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on AbbVie ABBV . And retail traders should know. We noticed this today when the positions ...
AbbVie Completes Acquisition of Landos Biopharma
KTBS Shreveport· 3 days agoWith the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like ...
AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands of...
JD Supra· 4 days agoOn May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been entrusted to the ...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 2 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare ...
Ad
related to: Abbvie